niflumic acid has been researched along with Osteoporosis in 3 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This constant concentration of ionised fluorine in the plasma contrasted with the marked and rapid variations which follow the ingestion of sodium fluoride, which is usually prescribed in the treatment of osteoporosis." | 7.66 | [Change in the plasma and urine levels of ionized fluorine under the influence of low doses of niflumic acid. Possible application to the treatment of osteoporosis]. ( Audran, M; Boiteau, HL; Caumon, JP; Prost, A; Rossel-Renac, F, 1980) |
| " After ruling out a hydrotelluric source of fluorine, the patient's fluorosis was linked to chronic use of niflumic acid, following the publication in 1978 of the 2 previously reported cases affected by this drug." | 5.26 | Niflumic acid-induced skeletal fluorosis: iatrogenic disease or therapeutic perspective for osteoporosis? ( Briancon, D; Courpron, P; Meunier, PJ; Smoller, JS, 1980) |
| " This constant concentration of ionised fluorine in the plasma contrasted with the marked and rapid variations which follow the ingestion of sodium fluoride, which is usually prescribed in the treatment of osteoporosis." | 3.66 | [Change in the plasma and urine levels of ionized fluorine under the influence of low doses of niflumic acid. Possible application to the treatment of osteoporosis]. ( Audran, M; Boiteau, HL; Caumon, JP; Prost, A; Rossel-Renac, F, 1980) |
| " After ruling out a hydrotelluric source of fluorine, the patient's fluorosis was linked to chronic use of niflumic acid, following the publication in 1978 of the 2 previously reported cases affected by this drug." | 1.26 | Niflumic acid-induced skeletal fluorosis: iatrogenic disease or therapeutic perspective for osteoporosis? ( Briancon, D; Courpron, P; Meunier, PJ; Smoller, JS, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meunier, PJ | 1 |
| Courpron, P | 1 |
| Smoller, JS | 1 |
| Briancon, D | 1 |
| Prost, A | 1 |
| Boiteau, HL | 1 |
| Rossel-Renac, F | 1 |
| Audran, M | 1 |
| Caumon, JP | 1 |
3 other studies available for niflumic acid and Osteoporosis
| Article | Year |
|---|---|
Fluoride osteosis with niflumic acid.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Fluorides; Humans; Mineral Waters; Ni | 2003 |
Niflumic acid-induced skeletal fluorosis: iatrogenic disease or therapeutic perspective for osteoporosis?
Topics: Adult; Bone Diseases; Female; Fluoride Poisoning; Humans; Nicotinic Acids; Niflumic Acid; Osteoporos | 1980 |
[Change in the plasma and urine levels of ionized fluorine under the influence of low doses of niflumic acid. Possible application to the treatment of osteoporosis].
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine; Human | 1980 |